Content in this section will include AAPM advocacy efforts, legislative news, public statements, etc.

AAPM Signs AMA Letter Discouraging CMS Expansion of NPP Services in IRF Settings

The American Medical Association (AMA), AAPM, and other leading health care organizations released a letter on June 11, 2020, responding to a proposal by the Centers for Medicare and Medicaid Services (CMS) that would al...
Continue reading
Topics:

AAPM Past President Steven Stanos, DO Discusses COVID-19's Impact on the Opioid Epidemic with AMA

This morning AAPM Past President Steven Stanos, DO participated in an AMA COVID-19 UPDATE podcast  to discuss how the pandemic has impacted the nation's opioid epidemic. Dr. Stanos also serves as AAPM's re...
Continue reading

AAPM and Multisociety Pain Workgroup Advocate for Facet Intervention Coverage

In preparation for the upcoming Medicare Administrative Contractor (MAC) Multi-jurisdictional Contractor Advisory Committee (CAC) meeting regarding facet interventions, AAPM partnered with several other professional medi...
Continue reading
Topics:

NAM Opioid Action Collaborative Virtual Symposium to Discuss the Opioid Epidemic, Particularly in the Context of the COVID-19 Pandemic

A May 21 National Academy of Medicine's Action Collaborative on Countering the U.S. Opioid Epidemic free virtual symposium will address combatting stigma against those with opioid use disorder, strengthening provider edu...
Continue reading
Topics:

NIH Convenes Virtual Consortium on Advances in Pain Research

On June 3, the NIH Pain Consortium will convene the 15th Annual NIH Pain Consortium Symposium on Advances in Pain Research as an all-virtual WebEx event. The symposium, " Technologies for Improved Understanding and Manag...
Continue reading

AMA Seeks Clarification, State Action to Protect Patients with Chronic Pain

The AMA joined the Indiana State Medical Association in seeking clarification from the state medical licensing board whether existing patients with chronic pain can be evaluated via telephone-only communication to satisf...
Continue reading

COVID-19 and Chronic Pain Survey Report

In order to better understand the challenges the pain community is facing and find ways to help, U.S. Pain Foundation recently conducted a survey of 664 individuals with pain about the impact of COVID-19.

Continue reading

FDA MedWatch Safety Alert: Ketorolac Tromethamine Injection

Fresenius Kabi USA, LLC is voluntarily recalling 13 lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL, 1 mL fill in a 2 mL amber vial and Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL fill in a...
Continue reading
Topics:
FDA

AHRQ Reports on Treatments for Chronic Pain

AHRQ completed three evidence reviews related to treatments for chronic pain. Final reports are available on the Effective Healthcare Website . Noninvasive Nonpharmacological Treatment for Chronic Pain (An Update) Nonopi...
Continue reading
Topics:

CDC Seeks Perspectives on Management of Acute and Chronic Pain

The Centers for Disease Control and Prevention is seeking stakeholders' perspectives on and experiences with pain and pain management, including, but not limited to, the benefits and harms of opioid use. CDC invites inpu...
Continue reading

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More